chr14-77329180-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_145870.3(GSTZ1):c.400G>A(p.Ala134Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000641 in 1,610,670 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_145870.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GSTZ1 | NM_145870.3 | c.400G>A | p.Ala134Thr | missense_variant | 6/9 | ENST00000216465.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GSTZ1 | ENST00000216465.10 | c.400G>A | p.Ala134Thr | missense_variant | 6/9 | 1 | NM_145870.3 |
Frequencies
GnomAD3 genomes AF: 0.000355 AC: 54AN: 152204Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000358 AC: 90AN: 251396Hom.: 0 AF XY: 0.000442 AC XY: 60AN XY: 135862
GnomAD4 exome AF: 0.000671 AC: 979AN: 1458466Hom.: 0 Cov.: 29 AF XY: 0.000657 AC XY: 477AN XY: 725798
GnomAD4 genome AF: 0.000355 AC: 54AN: 152204Hom.: 0 Cov.: 33 AF XY: 0.000256 AC XY: 19AN XY: 74348
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 08, 2022 | The c.400G>A (p.A134T) alteration is located in exon 6 (coding exon 6) of the GSTZ1 gene. This alteration results from a G to A substitution at nucleotide position 400, causing the alanine (A) at amino acid position 134 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at